Today, WebMD released The Cutting Edge of Cancer a five-part investigative video series developed in partnership with Robin Roberts and her independent production company, Rock’n Robin Productions. Through compelling patient stories and insights from medical experts, The Cutting Edge of Cancer, supported by Cancer Treatment Centers of America®, highlights some of the most promising areas of medical innovation in cancer care, including early detection, immunotherapy, genomic research, and integrative medicine.
To view the multimedia release go to:
http://www.multivu.com/players/English/7579755-webmd-robin-roberts-cutting-edge-of-cancer/
Germany is witnessing a constant rise in the number of private schools – there are roughly 3000 at present. The reason: Many parents have lost faith in state-run education, not least after the damning verdict and the abysmal ratings of the so-called 2006 PISA report. They prefer to send their children to privately funded schools. The percentage of private students has reached eight percent nationwide and has doubled since the mid-1990s, regardless of monthly tuition fees of an average 150 Euros per child. Private schools may follow a variety of different educational approaches. Nevertheless they are united in their ultimate objective of providing a better and individually-tailored education to their pupils. Hamburg’s Bugenhagen College is one of the schools that are going down this route. It is particularly worth mentioning that the college does not differentiate between non-handicapped and disabled youngsters.
Lung cancer is the most common cause of cancer-related death worldwide, with the highly malignant small cell lung cancer having the worst prognosis. In recent years the surge of immunotherapy has given cancer sufferers new hope.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64826-issels-recurrent-lung-cancer-responds-to-integrative-immunotherapy
Lung cancer is the most common cause of cancer-related death worldwide, with the highly malignant small cell lung cancer having the worst prognosis. In recent years the surge of immunotherapy has given cancer sufferers new hope.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/65511-issels-integrative-immunotherapy-non-toxic-treatment-lung-cancer
Lung cancer is the most common cause of cancer-related death worldwide, with the highly malignant small cell lung cancer having the worst prognosis. In recent years the surge of immunotherapy has given cancer sufferers new hope. While several leading cancer centers have only begun introducing immunotherapy, Issels has been a leader in Integrative Immunotherapy for decades.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7224051-issels-integrative-immunotherapy-lung-cancer-advanced-treatment
Brett Hoebel is one of the most sought-after lifestyle fitness experts in the country, you might remember him as one of the “secret” trainers on the long-running show, “The Biggest Loser®.” Since leaving the show, his integrative and holistic leading-edge fitness program has made Brett one of the most popular celebrity trainers in the nation. He is sharing his health and wellness strategies for people trying to get in shape in the New Year, or how to “fit” a workout regimen into your busy life that you will maintain year round.
There are so many healthy food and beverage options now to help family members of all ages manage their eating habits. Just like most parents, I'm not a fan of putting kids on a restrictive “diet,” but simple food-swaps can make a big impact, without the kids even knowing it. For instance, one suggested swap for the younger family members is Juicy Juice Fruitifuls. It has 35% less sugar than regular juice, a full serving of fruit and a taste kid's love. In fact, replacing a regular juice box with Fruitifuls every day can reduce annual sugar intake by 13 cups.
In recent years there has been a shift in the understanding of cancer. Immunotherapy with vaccines has been emerging as the most promising direction towards a decisive improvement of treatment outcomes.
The Dendritic Cell Vaccine has received FDA approval for prostate cancer and trials are now under way for a variety of other cancers. These vaccines are usually administered on their own.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64654-issels-integrative-immunotherapy-for-standard-therapy-resistant-cancers
